Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FDA announces more FluMist, possible imports

FDA announced Thursday the availability of an additional million doses of FluMist and its plans for an abbreviated process to approve and import foreign flu vaccines. MedImmune (MEDI) will increase its FluMist

Read the full 329 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers